| Risk and prognosis of endometrial cancer after tamoxifen for breast cancer L Bergman, MLR Beelen, MPW Gallee, H Hollema, J Benraadt, ... The Lancet 356 (9233), 881-887, 2000 | 644 | 2000 |
| Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre … SM de Boer, ME Powell, L Mileshkin, D Katsaros, P Bessette, ... The lancet oncology 19 (3), 295-309, 2018 | 571 | 2018 |
| Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva JA De Hullu, H Hollema, DA Piers, RHM Verheijen, PJ Van Diest, ... Journal of Clinical Oncology 18 (15), 2811-2816, 2000 | 435 | 2000 |
| In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft WB Nagengast, EG De Vries, GA Hospers, NH Mulder, JR De Jong, ... Journal of Nuclear Medicine 48 (8), 1313-1319, 2007 | 430 | 2007 |
| Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a … SM de Boer, ME Powell, L Mileshkin, D Katsaros, P Bessette, ... The lancet oncology 20 (9), 1273-1285, 2019 | 404 | 2019 |
| Association of hereditary nonpolyposis colorectal cancer–related tumors displaying low microsatellite instability with MSH6 germline mutations Y Wu, MJW Berends, RGJ Mensink, C Kempinga, RH Sijmons, ... The American Journal of Human Genetics 65 (5), 1291-1298, 1999 | 390 | 1999 |
| Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant MJW Berends, Y Wu, RH Sijmons, RGJ Mensink, T van der Sluis, ... The American Journal of Human Genetics 70 (1), 26-37, 2002 | 344 | 2002 |
| Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins BEC Plaat, H Hollema, WM Molenaar, GHT Broers, J Pijpe, MF Mastik, ... Journal of clinical oncology 18 (18), 3211-3220, 2000 | 338 | 2000 |
| Vulvar carcinoma: the price of less radical surgery JA De Hullu, H Hollema, S Lolkema, M Boezen, H Boonstra, MPM Burger, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2002 | 333 | 2002 |
| Tamoxifen treatment and gynecologic side effects: a review MJE Mourits, EGE De Vries, PHB Willemse, KA Ten Hoor, H Hollema, ... Obstetrics & Gynecology 97 (5), 855-866, 2001 | 332 | 2001 |
| Tissue distribution of the death ligand TRAIL and its receptors DC Spierings, EG de Vries, E Vellenga, FA van den Heuvel, JJ Koornstra, ... Journal of Histochemistry & Cytochemistry 52 (6), 821-831, 2004 | 318 | 2004 |
| Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study MH Oonk, BM van Hemel, H Hollema, JA de Hullu, AC Ansink, I Vergote, ... The lancet oncology 11 (7), 646-652, 2010 | 315 | 2010 |
| Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas MF Baay, WG Quint, J Koudstaal, H Hollema, JM Duk, MP Burger, E Stolz, ... Journal of clinical microbiology 34 (3), 745-747, 1996 | 310 | 1996 |
| Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections. S Poppema, H Hollema, L Visser, H Vos The American journal of pathology 127 (3), 418, 1987 | 293 | 1987 |
| Lymphvascular space involvement: an independent prognostic factor in endometrial cancer JM Briët, H Hollema, N Reesink, JG Aalders, MJE Mourits, KA ten Hoor, ... Gynecologic oncology 96 (3), 799-804, 2005 | 286 | 2005 |
| Histone Methyltransferase Gene SETD2 Is a Novel Tumor Suppressor Gene in Clear Cell Renal Cell Carcinoma G Duns, E van den Berg, I van Duivenbode, J Osinga, H Hollema, ... Cancer research 70 (11), 4287-4291, 2010 | 285 | 2010 |
| Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma L Qi, J Bart, LP Tan, I Platteel, T Sluis, S Huitema, G Harms, L Fu, ... BMC cancer 9, 1-8, 2009 | 279 | 2009 |
| Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages AH Klimp, H Hollema, C Kempinga, AGJ van der Zee, EGE de Vries, ... Cancer research 61 (19), 7305-7309, 2001 | 279 | 2001 |
| Management of extracolonic tumours in patients with Lynch syndrome JJ Koornstra, MJE Mourits, RH Sijmons, AM Leliveld, H Hollema, ... The lancet oncology 10 (4), 400-408, 2009 | 271 | 2009 |
| Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer RA De Jong, N Leffers, HM Boezen, KA Ten Hoor, AGJ van der Zee, ... Gynecologic oncology 114 (1), 105-110, 2009 | 259 | 2009 |
Elisabeth de VriesProfessor of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands在 umcg.nl 的电子邮件经过验证
